“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”

por Angrisani, A., Houben, R., Marcuse, F., Hochstenbag, M., Maessen, J., De Ruysscher, D., Peeters, S.
Publicado 2022

Tumor regression during radiotherapy for non-small cell lung cancer patients using cone-beam computed tomography images

por van Timmeren, J. E., van Elmpt, W., de Ruysscher, D., Reymen, B., Hansen, O., Brink, C.
Publicado 2019

Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study

por Degens, Juliette, De Ruysscher, D, Houben, Ruud, Kietselaer, Bastiaan, Bootsma, Gerben, Hendriks, Lizza, Huijbers, Ellen, Schols, Annemie, Dingemans, Anne-Marie C
Publicado 2020

Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcino...

por Willemsen, A. C. H., Degens, J. H. R. J., Baijens, L. W. J., Dingemans, A-M. C., Hoeben, A., Hoebers, F. J. P., De Ruysscher, D. K. M., Schols, A. M. W. J.
Publicado 2020

Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain

por Zegers, C.M.L., Offermann, C., Dijkstra, J., Compter, I., Hoebers, F.J.P., de Ruysscher, D., Anten, M.M., Broen, M.P.G., Postma, A.A., Hoeben, A., Hovinga, K.E., Van Elmpt, W., Eekers, D.B.P.
Publicado 2023